Compare STRL & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STRL | BIO |
|---|---|---|
| Founded | 1955 | 1952 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.4B | 8.7B |
| IPO Year | N/A | N/A |
| Metric | STRL | BIO |
|---|---|---|
| Price | $297.66 | $317.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $404.00 | $358.50 |
| AVG Volume (30 Days) | ★ 500.1K | 169.4K |
| Earning Date | 02-24-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 73.30 | N/A |
| EPS | ★ 10.21 | N/A |
| Revenue | $2,233,269,000.00 | ★ $2,557,500,000.00 |
| Revenue This Year | $14.76 | $1.62 |
| Revenue Next Year | $19.07 | $2.26 |
| P/E Ratio | $30.57 | ★ N/A |
| Revenue Growth | ★ 6.20 | N/A |
| 52 Week Low | $96.34 | $211.43 |
| 52 Week High | $419.14 | $373.69 |
| Indicator | STRL | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 41.24 | 55.58 |
| Support Level | $304.46 | $300.26 |
| Resistance Level | $332.84 | $328.25 |
| Average True Range (ATR) | 11.70 | 7.57 |
| MACD | 0.88 | 2.39 |
| Stochastic Oscillator | 14.76 | 66.16 |
Sterling Infrastructure Inc is a construction company that specializes in heavy civil infrastructure construction and infrastructure rehabilitation as well as residential construction projects. The company operates in three reportable segments namely, Transportation Solutions, E-Infrastructure Solutions, and Building Solution. Transportation Solutions include highways, roads, bridges, airfields, ports, light rail, and others. Building Solution projects include concrete foundations for single-family homes. E-Infrastructure Solutions include the services which are provided to large, blue-chip companies in the e-commerce, data center, distribution center, and warehousing, energy, mixed-use, and multi-family sectors. The majority of the revenue is generated from E-Infrastructure Solutions.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.